BSS Plus 250
"The U.S. Food and Drug Administration today expanded the approved use of Xgeva (denosumab) to treat adults and some adolescents with giant cell tumor of the bone (GCTB), a rare and usually non-cancerous tumor.
GCTB generally occurs in a"...
BSS Plus 250 mL
Postoperative inflammatory reactions as well as incidents of corneal edema and corneal decompensation have been reported. Their relationship to the use of BSS PLUS has not been established.
Read the BSS Plus 250 mL (balanced salt solution) Side Effects Center for a complete guide to possible side effects
No information provided.
Last reviewed on RxList: 10/30/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional BSS Plus 250 mL Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.